Market Place
Sourcing Support
Takeda hit with another pay-for-delay lawsuit
13 Apr 2023 //
FIERCE PHARMA
Zydus Life gets USFDA nod for Lubiprostone capsules
25 Mar 2023 //
BUSINESS STANDARD
Dr. Reddy`s Generic Lubiprostone Receives Approval in the U.S.
08 Feb 2022 //
FDA
Teva Pharms` Generic Lubiprostone Receives Approval in the U.S.
18 Jan 2022 //
FDA
Mallinckrodt investors stream for the exits as opioid-tied bankruptcy talk mount
07 Sep 2019 //
FIERCEPHARMA
Amneal Pharm`s Generic Lubiprostone Receives Tentative Approval in US
19 Jun 2019 //
FDA
5 Biopharma Trends to Watch in 2019
01 Jan 2019 //
GEN
Mallinckrodt spinoff to include 7 manufacturing sites in U.S. and Japan
19 Dec 2018 //
FIERCE PHARMA
Mallinckrodt to spin off generics business, but to keep options open
06 Dec 2018 //
REUTERS
Enforcement Report - Week of November 21, 2018
21 Nov 2018 //
FDA
AMITIZA® (lubiprostone) : Sucampo Pharmaceuticals vs. Sun Pharmaceutical
31 Oct 2018 //
PATENT LITIGATION
After 3 years of hunting a buyer, Trulance maker Synergy desperate for cash
26 Oct 2018 //
FIERCE PHARMA
Mallinckrodt pays $1.2bn for Sucampo Pharma
03 Jan 2018 //
PMLIVE
Deal spree, Mallinckrodt bags Sucampo & two late-stage rare disease drugs $1.2B
27 Dec 2017 //
ENDPTS
Amitiza (Lubiprostone): Sucampo & Takeda v. Amneal Pharmaceuticals
13 Apr 2017 //
PATENT LITIGATION
Synergy preps for Trulance launch with competitive pricing, experienced GI reps
06 Mar 2017 //
FIERCE PHARMA
Purdue inks Shionogi collab on constipation med as it awaits FDA approval
19 Dec 2016 //
FIERCE BIOTECH
Sucampo to buy Japanese pharma company, R-Tech Ueno for $278 million
27 Aug 2015 //
PHARMABIZ
Sucampo Announces Acceptance of New Drug Submission for AMITIZA(R) (lubiprostone) by Health Canada
30 Dec 2014 //
SUCAMPO PHARMACEUTICALS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.